| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vertebroplasty | 40 | 2024 | 78 | 14.760 |
Why?
|
| Low Back Pain | 55 | 2024 | 989 | 12.860 |
Why?
|
| Fractures, Compression | 39 | 2024 | 132 | 12.430 |
Why?
|
| Injections, Epidural | 43 | 2024 | 203 | 11.270 |
Why?
|
| Spinal Fractures | 50 | 2024 | 710 | 10.800 |
Why?
|
| Zygapophyseal Joint | 24 | 2024 | 129 | 10.660 |
Why?
|
| Medicare | 88 | 2024 | 6813 | 8.060 |
Why?
|
| Kyphoplasty | 19 | 2024 | 45 | 7.740 |
Why?
|
| Spinal Stenosis | 20 | 2024 | 259 | 7.110 |
Why?
|
| Patient Protection and Affordable Care Act | 37 | 2024 | 1188 | 6.980 |
Why?
|
| Back Pain | 24 | 2024 | 547 | 6.340 |
Why?
|
| Thrombectomy | 48 | 2023 | 676 | 5.580 |
Why?
|
| Radiculopathy | 13 | 2023 | 203 | 4.940 |
Why?
|
| Osteoporotic Fractures | 20 | 2024 | 417 | 4.870 |
Why?
|
| Stroke | 109 | 2023 | 9746 | 4.750 |
Why?
|
| Nerve Block | 17 | 2024 | 717 | 4.660 |
Why?
|
| Radiology | 31 | 2024 | 2106 | 4.530 |
Why?
|
| Lumbar Vertebrae | 35 | 2024 | 1885 | 4.360 |
Why?
|
| Neurosurgery | 21 | 2024 | 682 | 4.210 |
Why?
|
| Brain Ischemia | 52 | 2023 | 3001 | 4.160 |
Why?
|
| Steroids | 13 | 2022 | 937 | 3.930 |
Why?
|
| Endovascular Procedures | 59 | 2024 | 2215 | 3.860 |
Why?
|
| Anesthetics, Local | 21 | 2023 | 1005 | 3.850 |
Why?
|
| Neck Pain | 10 | 2022 | 191 | 3.730 |
Why?
|
| Evidence-Based Medicine | 43 | 2024 | 3700 | 3.720 |
Why?
|
| Bone Cements | 21 | 2023 | 327 | 3.540 |
Why?
|
| Physicians | 31 | 2023 | 4593 | 3.460 |
Why?
|
| International Classification of Diseases | 10 | 2016 | 935 | 2.940 |
Why?
|
| Health Expenditures | 24 | 2021 | 2390 | 2.920 |
Why?
|
| United States | 177 | 2024 | 72971 | 2.840 |
Why?
|
| Neuroradiography | 9 | 2015 | 71 | 2.750 |
Why?
|
| Neurosurgical Procedures | 22 | 2024 | 2075 | 2.740 |
Why?
|
| Sciatica | 4 | 2022 | 97 | 2.710 |
Why?
|
| Reimbursement Mechanisms | 15 | 2019 | 670 | 2.650 |
Why?
|
| Pain | 31 | 2023 | 5101 | 2.600 |
Why?
|
| Humans | 676 | 2025 | 767040 | 2.510 |
Why?
|
| Failed Back Surgery Syndrome | 4 | 2023 | 21 | 2.510 |
Why?
|
| Health Care Reform | 14 | 2017 | 1256 | 2.450 |
Why?
|
| Polymethyl Methacrylate | 8 | 2020 | 129 | 2.390 |
Why?
|
| Cerebral Angiography | 32 | 2023 | 1263 | 2.360 |
Why?
|
| Embolization, Therapeutic | 25 | 2024 | 1403 | 2.270 |
Why?
|
| Neurology | 11 | 2020 | 785 | 2.130 |
Why?
|
| Radiology, Interventional | 13 | 2024 | 483 | 2.020 |
Why?
|
| Radiography, Interventional | 17 | 2021 | 1129 | 1.960 |
Why?
|
| Platelet-Rich Plasma | 3 | 2024 | 180 | 1.950 |
Why?
|
| Prospective Payment System | 8 | 2018 | 134 | 1.910 |
Why?
|
| Diskectomy, Percutaneous | 7 | 2013 | 14 | 1.910 |
Why?
|
| Adrenal Cortex Hormones | 9 | 2021 | 1883 | 1.880 |
Why?
|
| Intracranial Aneurysm | 20 | 2021 | 1271 | 1.860 |
Why?
|
| Sacroiliac Joint | 9 | 2023 | 58 | 1.850 |
Why?
|
| Thrombolytic Therapy | 32 | 2023 | 2054 | 1.840 |
Why?
|
| Injections, Intra-Articular | 11 | 2024 | 284 | 1.780 |
Why?
|
| Analgesics, Opioid | 18 | 2023 | 3837 | 1.780 |
Why?
|
| Lidocaine | 7 | 2023 | 545 | 1.770 |
Why?
|
| Periodicals as Topic | 13 | 2020 | 1465 | 1.750 |
Why?
|
| Insurance, Health, Reimbursement | 8 | 2020 | 388 | 1.730 |
Why?
|
| Anesthesia, Epidural | 4 | 2021 | 232 | 1.710 |
Why?
|
| Randomized Controlled Trials as Topic | 40 | 2024 | 10393 | 1.700 |
Why?
|
| Cerebral Revascularization | 12 | 2018 | 260 | 1.690 |
Why?
|
| Spinal Cord | 8 | 2023 | 1811 | 1.690 |
Why?
|
| Fee Schedules | 8 | 2023 | 86 | 1.660 |
Why?
|
| Perioperative Care | 4 | 2024 | 1043 | 1.650 |
Why?
|
| Analgesics | 7 | 2019 | 1071 | 1.610 |
Why?
|
| Treatment Outcome | 138 | 2024 | 65295 | 1.560 |
Why?
|
| Practice Guidelines as Topic | 28 | 2024 | 7435 | 1.550 |
Why?
|
| National Health Insurance, United States | 5 | 2013 | 100 | 1.520 |
Why?
|
| Sacrum | 5 | 2018 | 274 | 1.520 |
Why?
|
| Coronavirus Infections | 12 | 2020 | 3112 | 1.510 |
Why?
|
| Medicare Payment Advisory Commission | 7 | 2018 | 14 | 1.510 |
Why?
|
| Health Policy | 11 | 2018 | 2698 | 1.510 |
Why?
|
| Medicaid | 13 | 2017 | 2836 | 1.500 |
Why?
|
| Pneumonia, Viral | 12 | 2020 | 3234 | 1.500 |
Why?
|
| Health Care Costs | 19 | 2018 | 3239 | 1.490 |
Why?
|
| Pandemics | 22 | 2023 | 8736 | 1.470 |
Why?
|
| Electric Stimulation Therapy | 4 | 2024 | 635 | 1.430 |
Why?
|
| Physician Incentive Plans | 5 | 2017 | 165 | 1.360 |
Why?
|
| Spinal Diseases | 6 | 2020 | 561 | 1.350 |
Why?
|
| Comparative Effectiveness Research | 5 | 2014 | 713 | 1.340 |
Why?
|
| Regenerative Medicine | 3 | 2024 | 306 | 1.330 |
Why?
|
| Denervation | 5 | 2023 | 265 | 1.320 |
Why?
|
| Arterial Occlusive Diseases | 12 | 2024 | 743 | 1.310 |
Why?
|
| United States Dept. of Health and Human Services | 6 | 2017 | 88 | 1.310 |
Why?
|
| Arthralgia | 5 | 2022 | 459 | 1.290 |
Why?
|
| Fee-for-Service Plans | 10 | 2023 | 713 | 1.290 |
Why?
|
| Tissue Plasminogen Activator | 17 | 2019 | 1164 | 1.280 |
Why?
|
| Fibrinolytic Agents | 19 | 2023 | 2079 | 1.270 |
Why?
|
| Epidural Space | 4 | 2021 | 123 | 1.260 |
Why?
|
| Anticoagulants | 8 | 2024 | 4854 | 1.250 |
Why?
|
| Fractures, Spontaneous | 4 | 2022 | 232 | 1.250 |
Why?
|
| Opioid-Related Disorders | 9 | 2022 | 2188 | 1.240 |
Why?
|
| Guidelines as Topic | 6 | 2013 | 1396 | 1.230 |
Why?
|
| Medicare Part B | 2 | 2023 | 116 | 1.200 |
Why?
|
| Reimbursement, Incentive | 5 | 2017 | 541 | 1.190 |
Why?
|
| Lumbosacral Region | 9 | 2022 | 294 | 1.190 |
Why?
|
| Bibliometrics | 6 | 2022 | 356 | 1.170 |
Why?
|
| Intracranial Arteriovenous Malformations | 8 | 2015 | 360 | 1.160 |
Why?
|
| Platelet Aggregation Inhibitors | 6 | 2024 | 2764 | 1.120 |
Why?
|
| Fluoroscopy | 12 | 2025 | 948 | 1.100 |
Why?
|
| Retrospective Studies | 106 | 2025 | 81659 | 1.100 |
Why?
|
| Radiology Information Systems | 2 | 2022 | 535 | 1.090 |
Why?
|
| Advisory Committees | 5 | 2017 | 797 | 1.080 |
Why?
|
| Societies, Medical | 18 | 2024 | 3964 | 1.080 |
Why?
|
| Tissue Adhesions | 2 | 2019 | 222 | 1.070 |
Why?
|
| Aged | 163 | 2024 | 171319 | 1.070 |
Why?
|
| Clinical Coding | 3 | 2020 | 187 | 1.070 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2024 | 505 | 1.060 |
Why?
|
| Decompression, Surgical | 6 | 2024 | 603 | 1.040 |
Why?
|
| Job Satisfaction | 3 | 2020 | 548 | 1.020 |
Why?
|
| Injections, Spinal | 3 | 2017 | 317 | 1.010 |
Why?
|
| Quality of Health Care | 8 | 2017 | 4306 | 1.010 |
Why?
|
| Pain Measurement | 20 | 2023 | 3584 | 0.990 |
Why?
|
| Spine | 5 | 2022 | 1139 | 0.980 |
Why?
|
| Male | 219 | 2025 | 364203 | 0.960 |
Why?
|
| Cerebrovascular Disorders | 12 | 2017 | 1478 | 0.950 |
Why?
|
| Current Procedural Terminology | 3 | 2019 | 101 | 0.950 |
Why?
|
| Peer Review | 3 | 2016 | 218 | 0.930 |
Why?
|
| Polyvinyls | 7 | 2016 | 153 | 0.930 |
Why?
|
| Analgesia, Epidural | 3 | 2017 | 332 | 0.930 |
Why?
|
| Journal Impact Factor | 5 | 2019 | 157 | 0.910 |
Why?
|
| Clinical Trials as Topic | 18 | 2019 | 8048 | 0.910 |
Why?
|
| Certification | 5 | 2019 | 420 | 0.900 |
Why?
|
| Occupational Medicine | 3 | 2008 | 116 | 0.870 |
Why?
|
| Female | 216 | 2025 | 396660 | 0.860 |
Why?
|
| Relative Value Scales | 4 | 2019 | 85 | 0.850 |
Why?
|
| Aged, 80 and over | 78 | 2024 | 59548 | 0.850 |
Why?
|
| Bupivacaine | 3 | 2023 | 414 | 0.850 |
Why?
|
| Radiation Dosage | 7 | 2025 | 1965 | 0.850 |
Why?
|
| Glucocorticoids | 4 | 2023 | 2163 | 0.840 |
Why?
|
| Sinus Thrombosis, Intracranial | 2 | 2022 | 111 | 0.840 |
Why?
|
| Dimethyl Sulfoxide | 6 | 2016 | 250 | 0.830 |
Why?
|
| Spinal Neoplasms | 8 | 2019 | 714 | 0.830 |
Why?
|
| Coccyx | 1 | 2022 | 13 | 0.830 |
Why?
|
| Burnout, Professional | 3 | 2022 | 711 | 0.830 |
Why?
|
| Anesthesia, Spinal | 4 | 2020 | 281 | 0.820 |
Why?
|
| Physician's Role | 3 | 2020 | 923 | 0.820 |
Why?
|
| Conflict of Interest | 5 | 2024 | 556 | 0.820 |
Why?
|
| Sacrococcygeal Region | 1 | 2022 | 52 | 0.810 |
Why?
|
| United States Food and Drug Administration | 7 | 2020 | 1672 | 0.800 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2020 | 1804 | 0.800 |
Why?
|
| Conscious Sedation | 4 | 2016 | 534 | 0.800 |
Why?
|
| Equipment and Supplies | 4 | 2013 | 272 | 0.790 |
Why?
|
| Aneurysm, Ruptured | 8 | 2020 | 455 | 0.780 |
Why?
|
| Cost-Benefit Analysis | 8 | 2020 | 5537 | 0.780 |
Why?
|
| Osteoporosis | 9 | 2023 | 1604 | 0.770 |
Why?
|
| Cerebral Veins | 1 | 2023 | 157 | 0.770 |
Why?
|
| Fees and Charges | 1 | 2022 | 189 | 0.760 |
Why?
|
| Petrosal Sinus Sampling | 7 | 2016 | 22 | 0.760 |
Why?
|
| Tomography, X-Ray Computed | 43 | 2024 | 20741 | 0.750 |
Why?
|
| American Medical Association | 4 | 2016 | 60 | 0.730 |
Why?
|
| Cervical Vertebrae | 6 | 2021 | 978 | 0.730 |
Why?
|
| Intracranial Thrombosis | 1 | 2022 | 109 | 0.730 |
Why?
|
| Vasospasm, Intracranial | 4 | 2021 | 207 | 0.720 |
Why?
|
| Stents | 20 | 2022 | 3193 | 0.720 |
Why?
|
| Peripheral Nerves | 1 | 2024 | 490 | 0.720 |
Why?
|
| Quality Assurance, Health Care | 10 | 2021 | 2174 | 0.710 |
Why?
|
| Placebo Effect | 2 | 2017 | 516 | 0.700 |
Why?
|
| Magnetic Resonance Imaging | 48 | 2024 | 36582 | 0.690 |
Why?
|
| Compassionate Use Trials | 1 | 2020 | 50 | 0.680 |
Why?
|
| Middle Aged | 150 | 2025 | 223233 | 0.680 |
Why?
|
| Research Design | 11 | 2019 | 6210 | 0.680 |
Why?
|
| Statistics as Topic | 2 | 2019 | 2350 | 0.680 |
Why?
|
| Single-Payer System | 1 | 2020 | 35 | 0.670 |
Why?
|
| Health Records, Personal | 1 | 2021 | 126 | 0.660 |
Why?
|
| Employee Performance Appraisal | 2 | 2016 | 86 | 0.660 |
Why?
|
| Joint Diseases | 1 | 2023 | 461 | 0.660 |
Why?
|
| Fentanyl | 3 | 2023 | 451 | 0.660 |
Why?
|
| Fellowships and Scholarships | 3 | 2024 | 1135 | 0.660 |
Why?
|
| Medical Informatics | 3 | 2016 | 744 | 0.650 |
Why?
|
| Health Services | 2 | 2014 | 755 | 0.650 |
Why?
|
| Central Nervous System Vascular Malformations | 5 | 2016 | 141 | 0.650 |
Why?
|
| Opiate Alkaloids | 1 | 2019 | 27 | 0.650 |
Why?
|
| Delivery of Health Care | 7 | 2020 | 5363 | 0.640 |
Why?
|
| Internal Fixators | 1 | 2020 | 183 | 0.630 |
Why?
|
| Radioisotopes | 4 | 2009 | 509 | 0.630 |
Why?
|
| Academies and Institutes | 2 | 2011 | 326 | 0.630 |
Why?
|
| Tramadol | 1 | 2019 | 63 | 0.630 |
Why?
|
| Authorship | 1 | 2022 | 289 | 0.620 |
Why?
|
| Sodium Chloride | 1 | 2021 | 580 | 0.620 |
Why?
|
| Editorial Policies | 3 | 2020 | 458 | 0.610 |
Why?
|
| Hypotension | 3 | 2015 | 888 | 0.600 |
Why?
|
| Neuralgia | 2 | 2016 | 619 | 0.600 |
Why?
|
| Review Literature as Topic | 3 | 2009 | 297 | 0.600 |
Why?
|
| Fracture Fixation, Internal | 6 | 2023 | 982 | 0.590 |
Why?
|
| Neck | 4 | 2016 | 736 | 0.590 |
Why?
|
| Game Theory | 1 | 2017 | 24 | 0.590 |
Why?
|
| Anesthesia, Local | 2 | 2023 | 277 | 0.580 |
Why?
|
| Quality-Adjusted Life Years | 4 | 2020 | 1741 | 0.580 |
Why?
|
| Lower Extremity | 3 | 2020 | 1217 | 0.580 |
Why?
|
| Medicine | 2 | 2019 | 944 | 0.570 |
Why?
|
| Reproducibility of Results | 29 | 2021 | 20169 | 0.570 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2021 | 1023 | 0.570 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2020 | 305 | 0.570 |
Why?
|
| Health Insurance Portability and Accountability Act | 3 | 2014 | 105 | 0.560 |
Why?
|
| Physician Executives | 1 | 2018 | 140 | 0.560 |
Why?
|
| Hemostasis | 2 | 2014 | 467 | 0.560 |
Why?
|
| Adult | 119 | 2025 | 223317 | 0.560 |
Why?
|
| Professional Practice Location | 1 | 2017 | 57 | 0.560 |
Why?
|
| Vertebrobasilar Insufficiency | 3 | 2024 | 112 | 0.550 |
Why?
|
| Nervous System Diseases | 5 | 2016 | 1660 | 0.550 |
Why?
|
| Reperfusion | 10 | 2020 | 268 | 0.550 |
Why?
|
| Federal Government | 2 | 2017 | 266 | 0.550 |
Why?
|
| Carotid Arteries | 4 | 2018 | 934 | 0.550 |
Why?
|
| Legislation, Medical | 2 | 2014 | 99 | 0.540 |
Why?
|
| Placebos | 2 | 2021 | 1660 | 0.540 |
Why?
|
| Mentors | 1 | 2022 | 672 | 0.540 |
Why?
|
| Cerebral Infarction | 11 | 2020 | 968 | 0.540 |
Why?
|
| Program Evaluation | 5 | 2017 | 2505 | 0.540 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2019 | 174 | 0.530 |
Why?
|
| Platelet Function Tests | 2 | 2015 | 275 | 0.530 |
Why?
|
| Specialization | 3 | 2019 | 778 | 0.530 |
Why?
|
| Empyema, Subdural | 1 | 2016 | 12 | 0.520 |
Why?
|
| Myelography | 1 | 2016 | 72 | 0.520 |
Why?
|
| Episode of Care | 1 | 2016 | 127 | 0.520 |
Why?
|
| Drug Prescriptions | 2 | 2017 | 1664 | 0.510 |
Why?
|
| Webcasts as Topic | 1 | 2016 | 21 | 0.510 |
Why?
|
| Embolectomy | 2 | 2016 | 130 | 0.510 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2016 | 138 | 0.510 |
Why?
|
| Triamcinolone | 1 | 2015 | 68 | 0.500 |
Why?
|
| Betamethasone | 1 | 2015 | 48 | 0.500 |
Why?
|
| Ambulatory Care Facilities | 3 | 2012 | 939 | 0.500 |
Why?
|
| Diagnostic Techniques and Procedures | 2 | 2014 | 216 | 0.500 |
Why?
|
| Complex Regional Pain Syndromes | 2 | 2014 | 122 | 0.500 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2019 | 281 | 0.490 |
Why?
|
| Hemorrhage | 6 | 2024 | 3464 | 0.490 |
Why?
|
| Safety-Based Drug Withdrawals | 1 | 2015 | 36 | 0.490 |
Why?
|
| Diagnostic Imaging | 8 | 2022 | 3530 | 0.490 |
Why?
|
| History, 21st Century | 7 | 2017 | 1574 | 0.490 |
Why?
|
| Infusions, Intra-Arterial | 7 | 2017 | 220 | 0.480 |
Why?
|
| Population Surveillance | 2 | 2016 | 2594 | 0.480 |
Why?
|
| Meta-Analysis as Topic | 3 | 2009 | 1364 | 0.480 |
Why?
|
| Epidemics | 2 | 2018 | 516 | 0.480 |
Why?
|
| Magnetic Resonance Angiography | 5 | 2016 | 1429 | 0.480 |
Why?
|
| Bone Neoplasms | 7 | 2016 | 2563 | 0.470 |
Why?
|
| Serum | 1 | 2016 | 206 | 0.470 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1161 | 0.470 |
Why?
|
| Hydrocodone | 1 | 2014 | 48 | 0.460 |
Why?
|
| Methylprednisolone | 1 | 2016 | 386 | 0.460 |
Why?
|
| Catheters, Indwelling | 3 | 2016 | 436 | 0.460 |
Why?
|
| Patients' Rooms | 1 | 2014 | 63 | 0.460 |
Why?
|
| Anesthesia | 2 | 2023 | 1595 | 0.460 |
Why?
|
| Buprenorphine | 1 | 2022 | 667 | 0.460 |
Why?
|
| Intraoperative Complications | 2 | 2015 | 1171 | 0.460 |
Why?
|
| Carotid Artery Diseases | 4 | 2014 | 872 | 0.460 |
Why?
|
| Education, Medical, Continuing | 5 | 2013 | 829 | 0.450 |
Why?
|
| Venous Thrombosis | 3 | 2022 | 1321 | 0.450 |
Why?
|
| Hospital Administration | 1 | 2017 | 350 | 0.450 |
Why?
|
| Rate Setting and Review | 1 | 2014 | 41 | 0.450 |
Why?
|
| Observation | 3 | 2012 | 310 | 0.450 |
Why?
|
| Autonomic Nerve Block | 1 | 2014 | 83 | 0.450 |
Why?
|
| Electronic Health Records | 6 | 2022 | 4881 | 0.450 |
Why?
|
| Clinical Protocols | 6 | 2024 | 1443 | 0.440 |
Why?
|
| Oxycodone | 1 | 2015 | 144 | 0.440 |
Why?
|
| Consensus | 5 | 2018 | 3207 | 0.440 |
Why?
|
| Hospital Units | 1 | 2014 | 141 | 0.440 |
Why?
|
| Governing Board | 1 | 2013 | 50 | 0.440 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2009 | 788 | 0.440 |
Why?
|
| Thoracic Vertebrae | 6 | 2022 | 613 | 0.430 |
Why?
|
| Device Approval | 2 | 2012 | 164 | 0.430 |
Why?
|
| Laminectomy | 1 | 2014 | 226 | 0.430 |
Why?
|
| Politics | 2 | 2017 | 822 | 0.430 |
Why?
|
| Congresses as Topic | 1 | 2018 | 812 | 0.420 |
Why?
|
| Choice Behavior | 2 | 2016 | 848 | 0.420 |
Why?
|
| Catheterization, Peripheral | 2 | 2016 | 346 | 0.420 |
Why?
|
| Prosthesis Failure | 2 | 2018 | 1208 | 0.420 |
Why?
|
| Automation | 2 | 2013 | 587 | 0.420 |
Why?
|
| Insurance, Health | 2 | 2017 | 2519 | 0.420 |
Why?
|
| Midazolam | 1 | 2014 | 267 | 0.410 |
Why?
|
| Spondylolisthesis | 1 | 2014 | 173 | 0.410 |
Why?
|
| Workers' Compensation | 1 | 2013 | 150 | 0.410 |
Why?
|
| Anesthetics, Intravenous | 2 | 2014 | 396 | 0.410 |
Why?
|
| Joint Instability | 1 | 2020 | 803 | 0.410 |
Why?
|
| Health Care Sector | 2 | 2013 | 196 | 0.410 |
Why?
|
| Purinergic P2X Receptor Antagonists | 1 | 2012 | 24 | 0.410 |
Why?
|
| Neuronavigation | 1 | 2014 | 169 | 0.400 |
Why?
|
| Nurse Anesthetists | 1 | 2012 | 24 | 0.400 |
Why?
|
| Spinal Puncture | 1 | 2014 | 284 | 0.400 |
Why?
|
| Quality Improvement | 7 | 2018 | 3854 | 0.400 |
Why?
|
| Physician Assistants | 1 | 2015 | 190 | 0.400 |
Why?
|
| Kyphosis | 2 | 2022 | 252 | 0.400 |
Why?
|
| Enbucrilate | 1 | 2012 | 29 | 0.400 |
Why?
|
| Triage | 6 | 2023 | 995 | 0.400 |
Why?
|
| Head | 6 | 2024 | 926 | 0.400 |
Why?
|
| Arthrography | 1 | 2012 | 149 | 0.390 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 1251 | 0.380 |
Why?
|
| Angioplasty, Balloon | 4 | 2012 | 592 | 0.380 |
Why?
|
| Health Services Research | 1 | 2019 | 1815 | 0.380 |
Why?
|
| Nurse Practitioners | 1 | 2015 | 271 | 0.380 |
Why?
|
| Catheterization, Central Venous | 2 | 2016 | 537 | 0.380 |
Why?
|
| Inventories, Hospital | 1 | 2011 | 4 | 0.380 |
Why?
|
| Hunger | 2 | 2013 | 207 | 0.380 |
Why?
|
| Databases, Factual | 14 | 2020 | 8068 | 0.380 |
Why?
|
| Osteoarthritis | 1 | 2019 | 1072 | 0.370 |
Why?
|
| Basilar Artery | 5 | 2024 | 207 | 0.370 |
Why?
|
| Appetite | 1 | 2013 | 247 | 0.370 |
Why?
|
| Prevalence | 12 | 2025 | 15851 | 0.370 |
Why?
|
| Hematoma, Subdural, Chronic | 2 | 2024 | 98 | 0.370 |
Why?
|
| Hypnotics and Sedatives | 3 | 2016 | 1193 | 0.370 |
Why?
|
| Medicare Part A | 1 | 2011 | 40 | 0.370 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2011 | 90 | 0.370 |
Why?
|
| Radio Frequency Identification Device | 1 | 2011 | 24 | 0.370 |
Why?
|
| Patient-Centered Care | 2 | 2011 | 1444 | 0.360 |
Why?
|
| Carotid Stenosis | 7 | 2022 | 858 | 0.360 |
Why?
|
| Vena Cava Filters | 2 | 2011 | 270 | 0.360 |
Why?
|
| Codes of Ethics | 1 | 2010 | 61 | 0.360 |
Why?
|
| Neoplasm Metastasis | 4 | 2015 | 4892 | 0.360 |
Why?
|
| Faculty, Medical | 1 | 2019 | 1227 | 0.360 |
Why?
|
| Polyradiculopathy | 1 | 2010 | 23 | 0.350 |
Why?
|
| Thrombosis | 4 | 2021 | 2954 | 0.350 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 499 | 0.350 |
Why?
|
| Attitude of Health Personnel | 3 | 2020 | 3928 | 0.350 |
Why?
|
| Education, Medical, Graduate | 3 | 2019 | 2420 | 0.350 |
Why?
|
| Product Labeling | 1 | 2011 | 75 | 0.350 |
Why?
|
| Deamino Arginine Vasopressin | 4 | 2016 | 87 | 0.350 |
Why?
|
| National Health Programs | 2 | 2011 | 443 | 0.350 |
Why?
|
| Brain Mapping | 9 | 2013 | 6597 | 0.350 |
Why?
|
| Prescriptions | 2 | 2023 | 388 | 0.350 |
Why?
|
| Health Personnel | 2 | 2023 | 3387 | 0.340 |
Why?
|
| Blood Vessels | 1 | 2016 | 1110 | 0.340 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2010 | 37 | 0.340 |
Why?
|
| Cicatrix | 1 | 2016 | 798 | 0.340 |
Why?
|
| Time Factors | 27 | 2021 | 40154 | 0.330 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2012 | 285 | 0.330 |
Why?
|
| Music Therapy | 1 | 2011 | 111 | 0.330 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 1768 | 0.330 |
Why?
|
| Laser Therapy | 3 | 2014 | 1108 | 0.330 |
Why?
|
| Needs Assessment | 2 | 2015 | 1141 | 0.330 |
Why?
|
| Policy | 2 | 2022 | 513 | 0.330 |
Why?
|
| Acetabulum | 3 | 2015 | 543 | 0.330 |
Why?
|
| Fractures, Bone | 2 | 2013 | 2062 | 0.320 |
Why?
|
| Biological Products | 1 | 2019 | 948 | 0.320 |
Why?
|
| Postoperative Complications | 13 | 2024 | 15824 | 0.320 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 10 | 2020 | 2811 | 0.320 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 724 | 0.320 |
Why?
|
| Practice Management, Medical | 3 | 2018 | 191 | 0.320 |
Why?
|
| Language | 4 | 2005 | 1550 | 0.320 |
Why?
|
| Disability Evaluation | 8 | 2023 | 1829 | 0.320 |
Why?
|
| Seasons | 1 | 2015 | 1523 | 0.310 |
Why?
|
| Angioplasty | 4 | 2013 | 355 | 0.310 |
Why?
|
| Bacterial Infections | 4 | 2021 | 1390 | 0.310 |
Why?
|
| Disease Management | 7 | 2019 | 2531 | 0.310 |
Why?
|
| Radiography | 13 | 2022 | 6975 | 0.310 |
Why?
|
| Environmental Medicine | 1 | 2008 | 15 | 0.310 |
Why?
|
| Neurophysiology | 1 | 2009 | 144 | 0.310 |
Why?
|
| State Government | 1 | 2011 | 388 | 0.310 |
Why?
|
| Aneurysm | 2 | 2010 | 343 | 0.300 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2012 | 878 | 0.300 |
Why?
|
| Food | 1 | 2013 | 766 | 0.300 |
Why?
|
| Orthopedic Procedures | 3 | 2014 | 1279 | 0.300 |
Why?
|
| Cerebral Cortex | 5 | 2016 | 5754 | 0.300 |
Why?
|
| Calcaneus | 1 | 2009 | 144 | 0.300 |
Why?
|
| Disclosure | 2 | 2013 | 755 | 0.300 |
Why?
|
| Anesthesiology | 1 | 2018 | 1137 | 0.300 |
Why?
|
| Hemoglobins | 1 | 2014 | 1531 | 0.300 |
Why?
|
| Sleep Deprivation | 2 | 2022 | 848 | 0.300 |
Why?
|
| Thiophenes | 1 | 2012 | 570 | 0.290 |
Why?
|
| Contrast Sensitivity | 4 | 2000 | 253 | 0.290 |
Why?
|
| Elastomers | 1 | 2008 | 69 | 0.290 |
Why?
|
| Angiography, Digital Subtraction | 6 | 2016 | 331 | 0.290 |
Why?
|
| Drug Utilization | 1 | 2014 | 1190 | 0.290 |
Why?
|
| Social Responsibility | 1 | 2010 | 382 | 0.290 |
Why?
|
| Cerebral Hemorrhage | 4 | 2012 | 2655 | 0.290 |
Why?
|
| Radiology Department, Hospital | 2 | 2022 | 409 | 0.280 |
Why?
|
| Spinal Cord Injuries | 3 | 2009 | 927 | 0.280 |
Why?
|
| Data Interpretation, Statistical | 7 | 2014 | 2698 | 0.280 |
Why?
|
| Prospective Studies | 38 | 2023 | 54886 | 0.280 |
Why?
|
| Diskectomy | 1 | 2009 | 203 | 0.280 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2012 | 452 | 0.280 |
Why?
|
| Reoperation | 5 | 2024 | 4325 | 0.280 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2428 | 0.280 |
Why?
|
| Databases, Bibliographic | 3 | 2013 | 128 | 0.280 |
Why?
|
| Suction | 2 | 2019 | 268 | 0.280 |
Why?
|
| Radiation Monitoring | 3 | 2021 | 106 | 0.280 |
Why?
|
| Spinal Cord Compression | 2 | 2024 | 234 | 0.280 |
Why?
|
| Drug Approval | 1 | 2014 | 820 | 0.280 |
Why?
|
| Comprehension | 1 | 2012 | 636 | 0.280 |
Why?
|
| Critical Illness | 1 | 2020 | 2753 | 0.270 |
Why?
|
| Patient Participation | 1 | 2016 | 1444 | 0.270 |
Why?
|
| Palliative Care | 4 | 2010 | 3641 | 0.270 |
Why?
|
| Injections, Intra-Arterial | 5 | 2014 | 181 | 0.270 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 3488 | 0.270 |
Why?
|
| Internship and Residency | 4 | 2024 | 5947 | 0.270 |
Why?
|
| Blood Pressure | 5 | 2015 | 8531 | 0.270 |
Why?
|
| Persistent Vegetative State | 2 | 2010 | 274 | 0.270 |
Why?
|
| Brain | 16 | 2022 | 27163 | 0.270 |
Why?
|
| Severity of Illness Index | 9 | 2015 | 15925 | 0.270 |
Why?
|
| Eating | 1 | 2013 | 1541 | 0.270 |
Why?
|
| Optical Illusions | 2 | 1997 | 40 | 0.260 |
Why?
|
| Forecasting | 6 | 2024 | 2936 | 0.260 |
Why?
|
| Comorbidity | 10 | 2024 | 10582 | 0.260 |
Why?
|
| Patient Selection | 9 | 2022 | 4256 | 0.260 |
Why?
|
| Bone Screws | 2 | 2020 | 533 | 0.260 |
Why?
|
| Addison Disease | 1 | 2006 | 48 | 0.260 |
Why?
|
| Consciousness Disorders | 1 | 2010 | 445 | 0.260 |
Why?
|
| Decision Making | 3 | 2023 | 3951 | 0.260 |
Why?
|
| Endarterectomy, Carotid | 5 | 2022 | 556 | 0.250 |
Why?
|
| Documentation | 3 | 2023 | 915 | 0.250 |
Why?
|
| Efficiency | 2 | 2020 | 479 | 0.250 |
Why?
|
| Radiotherapy | 2 | 2009 | 1500 | 0.250 |
Why?
|
| Insurance Coverage | 2 | 2017 | 1945 | 0.250 |
Why?
|
| Specialty Boards | 3 | 2019 | 235 | 0.250 |
Why?
|
| Self Report | 1 | 2017 | 3773 | 0.250 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 956 | 0.250 |
Why?
|
| Catheter Ablation | 5 | 2024 | 2787 | 0.250 |
Why?
|
| Standard of Care | 4 | 2013 | 569 | 0.250 |
Why?
|
| Age Distribution | 5 | 2016 | 2870 | 0.250 |
Why?
|
| Cohort Studies | 18 | 2023 | 41718 | 0.250 |
Why?
|
| Parkinsonian Disorders | 1 | 2008 | 285 | 0.250 |
Why?
|
| Follow-Up Studies | 20 | 2023 | 39317 | 0.250 |
Why?
|
| Motivation | 4 | 2016 | 2021 | 0.240 |
Why?
|
| Emergency Service, Hospital | 7 | 2024 | 7871 | 0.240 |
Why?
|
| Bone Density | 1 | 2018 | 3573 | 0.240 |
Why?
|
| Hemostatics | 3 | 2013 | 247 | 0.240 |
Why?
|
| Feasibility Studies | 5 | 2024 | 5311 | 0.240 |
Why?
|
| Infection Control | 1 | 2012 | 984 | 0.240 |
Why?
|
| Awareness | 2 | 2010 | 653 | 0.240 |
Why?
|
| Punctures | 4 | 2016 | 371 | 0.240 |
Why?
|
| Brain Infarction | 2 | 2020 | 285 | 0.240 |
Why?
|
| Multiple Myeloma | 2 | 2021 | 5186 | 0.240 |
Why?
|
| Ambulatory Care | 2 | 2016 | 2780 | 0.240 |
Why?
|
| Obesity | 6 | 2025 | 13085 | 0.240 |
Why?
|
| Multicenter Studies as Topic | 5 | 2016 | 1733 | 0.240 |
Why?
|
| Genes, Homeobox | 3 | 1999 | 289 | 0.240 |
Why?
|
| Cost Control | 3 | 2017 | 627 | 0.230 |
Why?
|
| Quality of Life | 9 | 2023 | 13485 | 0.230 |
Why?
|
| Surgical Procedures, Operative | 2 | 2015 | 1931 | 0.230 |
Why?
|
| Adrenocorticotropic Hormone | 4 | 2016 | 619 | 0.220 |
Why?
|
| Implantable Neurostimulators | 1 | 2024 | 75 | 0.220 |
Why?
|
| Gadolinium DTPA | 3 | 2013 | 823 | 0.220 |
Why?
|
| Cost of Illness | 1 | 2014 | 1951 | 0.220 |
Why?
|
| Somatosensory Cortex | 3 | 2008 | 506 | 0.220 |
Why?
|
| Alcoholism | 5 | 1999 | 1980 | 0.220 |
Why?
|
| Intracranial Hemorrhages | 5 | 2019 | 810 | 0.220 |
Why?
|
| Surgery, Computer-Assisted | 4 | 2020 | 996 | 0.220 |
Why?
|
| Contracts | 1 | 2023 | 60 | 0.220 |
Why?
|
| Drug Industry | 1 | 2010 | 791 | 0.220 |
Why?
|
| Child Health Services | 1 | 2009 | 645 | 0.210 |
Why?
|
| History, 20th Century | 3 | 2017 | 2765 | 0.210 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2023 | 70 | 0.210 |
Why?
|
| Cross Infection | 1 | 2012 | 1426 | 0.210 |
Why?
|
| Hemostasis, Surgical | 1 | 2003 | 128 | 0.210 |
Why?
|
| Guideline Adherence | 2 | 2010 | 2232 | 0.210 |
Why?
|
| Delirium | 1 | 2015 | 1698 | 0.210 |
Why?
|
| Evoked Potentials, Somatosensory | 2 | 2008 | 240 | 0.210 |
Why?
|
| Arrestin | 2 | 1999 | 30 | 0.210 |
Why?
|
| Brain Diseases | 3 | 2020 | 1551 | 0.210 |
Why?
|
| Middle Cerebral Artery | 5 | 2018 | 271 | 0.200 |
Why?
|
| Dissent and Disputes | 1 | 2024 | 150 | 0.200 |
Why?
|
| Serpins | 2 | 2014 | 246 | 0.200 |
Why?
|
| Multiple Sclerosis | 7 | 2011 | 3229 | 0.200 |
Why?
|
| Touch | 2 | 2005 | 313 | 0.200 |
Why?
|
| Hemostatic Techniques | 1 | 2003 | 116 | 0.200 |
Why?
|
| Acetylglucosamine | 1 | 2003 | 188 | 0.200 |
Why?
|
| Radiation Protection | 2 | 2019 | 428 | 0.190 |
Why?
|
| Piperazines | 1 | 2012 | 2548 | 0.190 |
Why?
|
| Observer Variation | 6 | 2017 | 2616 | 0.190 |
Why?
|
| Clinical Competence | 6 | 2015 | 4859 | 0.190 |
Why?
|
| Research | 3 | 2020 | 1977 | 0.190 |
Why?
|
| Eye Proteins | 3 | 2014 | 628 | 0.180 |
Why?
|
| Nerve Growth Factors | 2 | 2014 | 564 | 0.180 |
Why?
|
| Nerve Net | 2 | 2010 | 2307 | 0.180 |
Why?
|
| Equipment Design | 3 | 2016 | 3489 | 0.180 |
Why?
|
| Industry | 2 | 2015 | 362 | 0.180 |
Why?
|
| Blindness, Cortical | 1 | 2000 | 17 | 0.180 |
Why?
|
| Trauma Centers | 2 | 2024 | 950 | 0.180 |
Why?
|
| Injections | 3 | 2023 | 839 | 0.180 |
Why?
|
| Costs and Cost Analysis | 2 | 2019 | 1666 | 0.180 |
Why?
|
| Public Health | 1 | 2014 | 2681 | 0.180 |
Why?
|
| Arteriovenous Fistula | 2 | 2015 | 320 | 0.180 |
Why?
|
| Crystallography, X-Ray | 6 | 1999 | 1947 | 0.180 |
Why?
|
| Chronic Disease | 8 | 2020 | 9362 | 0.180 |
Why?
|
| Pituitary ACTH Hypersecretion | 4 | 2016 | 180 | 0.170 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1997 | 167 | 0.170 |
Why?
|
| Patient Care Team | 5 | 2019 | 2516 | 0.170 |
Why?
|
| Contrast Media | 9 | 2020 | 5329 | 0.170 |
Why?
|
| Oral Surgical Procedures, Preprosthetic | 1 | 1999 | 26 | 0.170 |
Why?
|
| Aspartic Acid | 3 | 2011 | 575 | 0.170 |
Why?
|
| Curettage | 1 | 2019 | 74 | 0.170 |
Why?
|
| Cataract Extraction | 3 | 2014 | 464 | 0.170 |
Why?
|
| Vision, Ocular | 2 | 2000 | 457 | 0.160 |
Why?
|
| Alcohol Drinking | 3 | 1997 | 4045 | 0.160 |
Why?
|
| Risk Factors | 18 | 2024 | 74886 | 0.160 |
Why?
|
| Anesthesia, General | 3 | 2023 | 1188 | 0.160 |
Why?
|
| Dental Restoration Failure | 1 | 1999 | 155 | 0.160 |
Why?
|
| Double-Blind Method | 3 | 2023 | 12451 | 0.160 |
Why?
|
| Iodine | 2 | 2012 | 285 | 0.160 |
Why?
|
| Umbilical Cord | 1 | 2020 | 179 | 0.150 |
Why?
|
| Central Nervous System Depressants | 2 | 2018 | 163 | 0.150 |
Why?
|
| Medullary Sponge Kidney | 1 | 2018 | 2 | 0.150 |
Why?
|
| Device Removal | 1 | 2023 | 643 | 0.150 |
Why?
|
| After-Hours Care | 1 | 2019 | 102 | 0.150 |
Why?
|
| Cartilage | 1 | 2022 | 811 | 0.150 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 232 | 0.150 |
Why?
|
| Pattern Recognition, Visual | 2 | 2010 | 820 | 0.150 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2020 | 263 | 0.150 |
Why?
|
| Temporal Lobe | 3 | 2005 | 1717 | 0.150 |
Why?
|
| Maxillary Sinus | 1 | 1999 | 172 | 0.150 |
Why?
|
| False Positive Reactions | 1 | 2020 | 959 | 0.150 |
Why?
|
| Flank Pain | 1 | 2018 | 44 | 0.150 |
Why?
|
| Ablation Techniques | 1 | 2021 | 255 | 0.150 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2014 | 362 | 0.150 |
Why?
|
| Flicker Fusion | 1 | 1997 | 14 | 0.140 |
Why?
|
| Heroin | 1 | 2018 | 120 | 0.140 |
Why?
|
| Income | 3 | 2016 | 1877 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 258 | 0.140 |
Why?
|
| Osteolysis | 1 | 2019 | 274 | 0.140 |
Why?
|
| Workflow | 2 | 2020 | 859 | 0.140 |
Why?
|
| Blood Platelets | 2 | 2020 | 2464 | 0.140 |
Why?
|
| Alanine | 1 | 2020 | 613 | 0.140 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 171 | 0.140 |
Why?
|
| Quality Indicators, Health Care | 3 | 2017 | 1804 | 0.140 |
Why?
|
| Referral and Consultation | 4 | 2019 | 3618 | 0.140 |
Why?
|
| Computers, Handheld | 2 | 2016 | 211 | 0.140 |
Why?
|
| Verbal Behavior | 2 | 2010 | 328 | 0.140 |
Why?
|
| Cognition | 3 | 2016 | 7059 | 0.140 |
Why?
|
| Inpatients | 3 | 2019 | 2563 | 0.130 |
Why?
|
| Syndrome | 3 | 2020 | 3271 | 0.130 |
Why?
|
| Anesthesia, Conduction | 1 | 2020 | 264 | 0.130 |
Why?
|
| Chest Pain | 1 | 2023 | 1101 | 0.130 |
Why?
|
| Writing | 2 | 2015 | 200 | 0.130 |
Why?
|
| Cataract | 2 | 2014 | 837 | 0.130 |
Why?
|
| Warfarin | 1 | 2005 | 1493 | 0.130 |
Why?
|
| Lumbosacral Plexus | 1 | 2016 | 53 | 0.130 |
Why?
|
| Sensitivity and Specificity | 14 | 2014 | 14672 | 0.130 |
Why?
|
| Cerebral Arteries | 1 | 2018 | 490 | 0.130 |
Why?
|
| Telemedicine | 3 | 2021 | 3110 | 0.130 |
Why?
|
| Sex Factors | 5 | 2025 | 10622 | 0.130 |
Why?
|
| Sample Size | 1 | 2019 | 845 | 0.130 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2019 | 497 | 0.130 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 427 | 0.130 |
Why?
|
| Models, Economic | 2 | 2019 | 719 | 0.130 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2000 | 519 | 0.130 |
Why?
|
| Fees, Medical | 1 | 2016 | 111 | 0.130 |
Why?
|
| Preoperative Care | 3 | 2000 | 2252 | 0.130 |
Why?
|
| Administrative Personnel | 1 | 2017 | 185 | 0.120 |
Why?
|
| Pilot Projects | 5 | 2021 | 8732 | 0.120 |
Why?
|
| Hemangioma | 1 | 2020 | 727 | 0.120 |
Why?
|
| China | 2 | 2020 | 2394 | 0.120 |
Why?
|
| Analgesia | 1 | 2020 | 461 | 0.120 |
Why?
|
| Leadership | 2 | 2018 | 1394 | 0.120 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 856 | 0.120 |
Why?
|
| Radiation Injuries | 1 | 2023 | 1196 | 0.120 |
Why?
|
| Compensation and Redress | 1 | 2015 | 66 | 0.120 |
Why?
|
| Risk | 4 | 2016 | 9606 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2016 | 2978 | 0.120 |
Why?
|
| Universities | 1 | 2020 | 1004 | 0.120 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 1999 | 115 | 0.120 |
Why?
|
| Workload | 2 | 2018 | 849 | 0.120 |
Why?
|
| Cost Savings | 2 | 2019 | 904 | 0.120 |
Why?
|
| Genes, Insect | 1 | 1995 | 265 | 0.120 |
Why?
|
| Fasting | 2 | 2013 | 1607 | 0.120 |
Why?
|
| Nociceptors | 1 | 1998 | 460 | 0.120 |
Why?
|
| Patient Transfer | 2 | 2021 | 788 | 0.120 |
Why?
|
| Chordoma | 1 | 2018 | 349 | 0.120 |
Why?
|
| Bone Transplantation | 1 | 1999 | 921 | 0.120 |
Why?
|
| Anesthesia, Caudal | 1 | 2014 | 33 | 0.120 |
Why?
|
| Viral Vaccines | 1 | 2020 | 596 | 0.120 |
Why?
|
| Publishing | 2 | 2020 | 837 | 0.120 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 643 | 0.120 |
Why?
|
| Young Adult | 18 | 2020 | 59980 | 0.120 |
Why?
|
| Vasodilator Agents | 2 | 2017 | 988 | 0.120 |
Why?
|
| Constriction, Pathologic | 2 | 2023 | 1104 | 0.120 |
Why?
|
| Combined Modality Therapy | 7 | 2021 | 8535 | 0.120 |
Why?
|
| Nursing Care | 1 | 2015 | 65 | 0.110 |
Why?
|
| Adipose Tissue | 6 | 1997 | 3324 | 0.110 |
Why?
|
| DNA | 3 | 1997 | 7210 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 6 | 2017 | 2672 | 0.110 |
Why?
|
| Computer-Aided Design | 1 | 2016 | 290 | 0.110 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2012 | 138 | 0.110 |
Why?
|
| Refusal to Participate | 1 | 2014 | 30 | 0.110 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 235 | 0.110 |
Why?
|
| Silo Filler's Disease | 1 | 1993 | 1 | 0.110 |
Why?
|
| Hospital Charges | 1 | 2016 | 345 | 0.110 |
Why?
|
| Musculoskeletal Diseases | 1 | 2020 | 599 | 0.110 |
Why?
|
| Inflation, Economic | 1 | 2014 | 30 | 0.110 |
Why?
|
| Impotence, Vasculogenic | 1 | 2013 | 13 | 0.110 |
Why?
|
| Injections, Intravenous | 3 | 2012 | 1377 | 0.110 |
Why?
|
| Gross Domestic Product | 1 | 2014 | 77 | 0.110 |
Why?
|
| Management Audit | 1 | 2013 | 23 | 0.110 |
Why?
|
| Kidney Calculi | 1 | 2018 | 458 | 0.110 |
Why?
|
| Telephone | 1 | 2017 | 629 | 0.110 |
Why?
|
| Anti-Anxiety Agents | 1 | 2016 | 405 | 0.110 |
Why?
|
| Monte Carlo Method | 2 | 2009 | 1250 | 0.110 |
Why?
|
| Brachytherapy | 1 | 2021 | 1220 | 0.110 |
Why?
|
| Perfusion Imaging | 1 | 2014 | 193 | 0.110 |
Why?
|
| Ethanol | 2 | 2018 | 1330 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2019 | 956 | 0.110 |
Why?
|
| Drug and Narcotic Control | 1 | 2014 | 145 | 0.110 |
Why?
|
| Length of Stay | 2 | 2017 | 6489 | 0.110 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 1078 | 0.110 |
Why?
|
| Efficiency, Organizational | 3 | 2017 | 697 | 0.110 |
Why?
|
| Acute Disease | 7 | 2019 | 7236 | 0.100 |
Why?
|
| Operating Rooms | 1 | 2019 | 790 | 0.100 |
Why?
|
| Vaccination | 2 | 2023 | 3434 | 0.100 |
Why?
|
| Intermittent Claudication | 1 | 2015 | 305 | 0.100 |
Why?
|
| Government Agencies | 1 | 2013 | 161 | 0.100 |
Why?
|
| Drug Therapy, Combination | 3 | 2020 | 6310 | 0.100 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2013 | 86 | 0.100 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2014 | 196 | 0.100 |
Why?
|
| Neurosciences | 1 | 2017 | 384 | 0.100 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 7848 | 0.100 |
Why?
|
| Carcinoma, Small Cell | 1 | 1995 | 419 | 0.100 |
Why?
|
| Neuropsychological Tests | 4 | 2016 | 7121 | 0.100 |
Why?
|
| Cushing Syndrome | 2 | 2011 | 241 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2016 | 485 | 0.100 |
Why?
|
| Meningeal Arteries | 2 | 2024 | 66 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 832 | 0.100 |
Why?
|
| Dietary Fats | 4 | 1997 | 2001 | 0.100 |
Why?
|
| Algorithms | 4 | 2019 | 14098 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 1999 | 1408 | 0.100 |
Why?
|
| Academic Medical Centers | 2 | 2020 | 2783 | 0.100 |
Why?
|
| Hospitals | 3 | 2021 | 3883 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2020 | 2710 | 0.100 |
Why?
|
| Cesarean Section | 2 | 2000 | 1419 | 0.100 |
Why?
|
| Visual Perception | 3 | 2000 | 1392 | 0.100 |
Why?
|
| Clot Retraction | 1 | 2011 | 13 | 0.100 |
Why?
|
| Visual Cortex | 2 | 2000 | 1081 | 0.100 |
Why?
|
| Probability | 1 | 2017 | 2476 | 0.100 |
Why?
|
| Prostheses and Implants | 3 | 2024 | 1275 | 0.100 |
Why?
|
| Attention | 2 | 2005 | 2413 | 0.100 |
Why?
|
| Arm | 1 | 2015 | 591 | 0.100 |
Why?
|
| Patient Dropouts | 1 | 2014 | 411 | 0.100 |
Why?
|
| Perioperative Period | 1 | 2013 | 252 | 0.090 |
Why?
|
| Animals | 28 | 2016 | 168965 | 0.090 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 542 | 0.090 |
Why?
|
| Europe | 1 | 2018 | 3432 | 0.090 |
Why?
|
| Risk Assessment | 8 | 2021 | 24299 | 0.090 |
Why?
|
| Dental Implants | 1 | 1999 | 790 | 0.090 |
Why?
|
| Incidence | 5 | 2024 | 21526 | 0.090 |
Why?
|
| Cues | 2 | 2013 | 877 | 0.090 |
Why?
|
| Tantalum | 1 | 2011 | 54 | 0.090 |
Why?
|
| Pain Clinics | 1 | 2011 | 50 | 0.090 |
Why?
|
| Taxes | 1 | 2013 | 220 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2013 | 195 | 0.090 |
Why?
|
| Vertebral Artery Dissection | 1 | 2011 | 48 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 2000 | 1255 | 0.090 |
Why?
|
| Postural Balance | 1 | 2015 | 638 | 0.090 |
Why?
|
| Taxoids | 1 | 2014 | 665 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 2330 | 0.090 |
Why?
|
| Physical Stimulation | 2 | 2005 | 514 | 0.090 |
Why?
|
| Malpractice | 1 | 2015 | 561 | 0.090 |
Why?
|
| Prostatic Hyperplasia | 1 | 2014 | 514 | 0.090 |
Why?
|
| Biomedical Research | 2 | 2017 | 3464 | 0.090 |
Why?
|
| Spinal Cord Diseases | 1 | 2013 | 291 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2011 | 3684 | 0.090 |
Why?
|
| Motor Activity | 1 | 2000 | 2713 | 0.090 |
Why?
|
| Drosophila Proteins | 2 | 1999 | 1705 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 1999 | 2429 | 0.090 |
Why?
|
| Reaction Time | 2 | 2016 | 2086 | 0.090 |
Why?
|
| Health Care Rationing | 1 | 2013 | 435 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 252 | 0.090 |
Why?
|
| International Educational Exchange | 1 | 2010 | 54 | 0.090 |
Why?
|
| Needles | 1 | 2013 | 461 | 0.090 |
Why?
|
| Nurse Administrators | 1 | 2010 | 45 | 0.080 |
Why?
|
| Automobiles | 1 | 2010 | 103 | 0.080 |
Why?
|
| Echo-Planar Imaging | 3 | 1999 | 648 | 0.080 |
Why?
|
| Fatty Acids | 3 | 1997 | 1806 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 2016 | 1137 | 0.080 |
Why?
|
| Adolescent | 24 | 2019 | 89046 | 0.080 |
Why?
|
| Philosophy | 1 | 2010 | 69 | 0.080 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 15424 | 0.080 |
Why?
|
| Organizational Innovation | 1 | 2013 | 539 | 0.080 |
Why?
|
| Outpatients | 2 | 2020 | 1600 | 0.080 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1989 | 393 | 0.080 |
Why?
|
| Prognosis | 8 | 2017 | 29963 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 4054 | 0.080 |
Why?
|
| Models, Organizational | 1 | 2013 | 548 | 0.080 |
Why?
|
| Radio Waves | 1 | 2011 | 245 | 0.080 |
Why?
|
| Logistic Models | 5 | 2019 | 13284 | 0.080 |
Why?
|
| Ischemia | 1 | 2018 | 1905 | 0.080 |
Why?
|
| Venous Insufficiency | 1 | 2010 | 109 | 0.080 |
Why?
|
| Reward | 2 | 2013 | 980 | 0.080 |
Why?
|
| Brain Stem | 2 | 2014 | 858 | 0.080 |
Why?
|
| Lenses, Intraocular | 1 | 1991 | 141 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 6513 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2016 | 2120 | 0.080 |
Why?
|
| Food Preferences | 2 | 2012 | 397 | 0.080 |
Why?
|
| Quadriplegia | 1 | 2010 | 227 | 0.080 |
Why?
|
| Neural Inhibition | 2 | 2008 | 589 | 0.080 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2012 | 208 | 0.080 |
Why?
|
| Nurse's Role | 1 | 2010 | 187 | 0.080 |
Why?
|
| Nicardipine | 1 | 2008 | 59 | 0.080 |
Why?
|
| Glasgow Coma Scale | 1 | 2010 | 574 | 0.080 |
Why?
|
| Lens, Crystalline | 1 | 1991 | 387 | 0.080 |
Why?
|
| Hospitals, General | 1 | 2013 | 804 | 0.080 |
Why?
|
| Airway Obstruction | 1 | 1993 | 672 | 0.080 |
Why?
|
| Sex Distribution | 2 | 2014 | 2276 | 0.080 |
Why?
|
| Pain, Intractable | 1 | 2009 | 132 | 0.080 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 2227 | 0.080 |
Why?
|
| Artifacts | 2 | 2014 | 1904 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2018 | 1307 | 0.070 |
Why?
|
| Catheters | 1 | 2011 | 428 | 0.070 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2011 | 538 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1278 | 0.070 |
Why?
|
| Photic Stimulation | 2 | 2013 | 1989 | 0.070 |
Why?
|
| Data Collection | 2 | 2019 | 3321 | 0.070 |
Why?
|
| Drug Labeling | 1 | 2010 | 251 | 0.070 |
Why?
|
| Mandibular Fractures | 1 | 2008 | 77 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2019 | 1304 | 0.070 |
Why?
|
| Population Groups | 1 | 2009 | 209 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 1936 | 0.070 |
Why?
|
| Neoplasms | 3 | 2023 | 22350 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 4357 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3070 | 0.070 |
Why?
|
| Time | 1 | 2009 | 551 | 0.070 |
Why?
|
| Protein Conformation | 4 | 1999 | 3948 | 0.070 |
Why?
|
| Leg | 1 | 2012 | 1087 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2009 | 21178 | 0.070 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 1512 | 0.070 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2010 | 312 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2025 | 13048 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2014 | 2931 | 0.070 |
Why?
|
| Alberta | 2 | 2020 | 67 | 0.070 |
Why?
|
| Image Enhancement | 2 | 2013 | 2867 | 0.070 |
Why?
|
| Carotid Artery, Internal | 3 | 2018 | 440 | 0.070 |
Why?
|
| Blood Pressure Determination | 1 | 2010 | 646 | 0.070 |
Why?
|
| Arthroplasty | 1 | 2009 | 308 | 0.070 |
Why?
|
| Movement | 3 | 2008 | 1473 | 0.070 |
Why?
|
| Chymopapain | 1 | 2006 | 4 | 0.070 |
Why?
|
| Motor Neuron Disease | 1 | 2007 | 98 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 1995 | 1722 | 0.070 |
Why?
|
| Functional Laterality | 3 | 2010 | 2245 | 0.070 |
Why?
|
| Patient Discharge | 3 | 2014 | 3467 | 0.070 |
Why?
|
| Informed Consent | 2 | 2023 | 1010 | 0.070 |
Why?
|
| Platinum | 1 | 2007 | 219 | 0.070 |
Why?
|
| Brain Neoplasms | 3 | 2012 | 9108 | 0.070 |
Why?
|
| Mortality | 1 | 2017 | 2909 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 2 | 2003 | 1623 | 0.060 |
Why?
|
| Creatine | 2 | 2007 | 424 | 0.060 |
Why?
|
| Students, Medical | 1 | 2019 | 1965 | 0.060 |
Why?
|
| Radiometry | 2 | 2009 | 818 | 0.060 |
Why?
|
| Nuclear Medicine | 1 | 2009 | 262 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 2337 | 0.060 |
Why?
|
| Tinnitus | 1 | 2008 | 197 | 0.060 |
Why?
|
| Corpus Striatum | 1 | 2012 | 1217 | 0.060 |
Why?
|
| Ankle Joint | 1 | 2009 | 452 | 0.060 |
Why?
|
| Utilization Review | 1 | 2007 | 381 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2016 | 8940 | 0.060 |
Why?
|
| Encephalomalacia | 1 | 2005 | 18 | 0.060 |
Why?
|
| Child | 13 | 2023 | 80771 | 0.060 |
Why?
|
| Safety Management | 1 | 2011 | 765 | 0.060 |
Why?
|
| Reference Values | 3 | 2021 | 4918 | 0.060 |
Why?
|
| Base Composition | 2 | 1995 | 291 | 0.060 |
Why?
|
| Patients | 2 | 2024 | 908 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 12069 | 0.060 |
Why?
|
| Time and Motion Studies | 2 | 2015 | 143 | 0.060 |
Why?
|
| Craniocerebral Trauma | 2 | 2010 | 493 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2013 | 2114 | 0.060 |
Why?
|
| Cytokines | 1 | 2020 | 7446 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 2013 | 1322 | 0.060 |
Why?
|
| Italy | 2 | 2020 | 856 | 0.060 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2004 | 54 | 0.060 |
Why?
|
| Esophageal Neoplasms | 1 | 1995 | 1661 | 0.060 |
Why?
|
| Tibia | 1 | 2010 | 1075 | 0.060 |
Why?
|
| Pressure | 1 | 2008 | 1172 | 0.060 |
Why?
|
| Organizational Case Studies | 2 | 2017 | 301 | 0.060 |
Why?
|
| Suburban Population | 1 | 2023 | 54 | 0.060 |
Why?
|
| Cardiology | 1 | 2015 | 1701 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 2 | 1999 | 874 | 0.060 |
Why?
|
| Movement Disorders | 1 | 2008 | 462 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2627 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2008 | 877 | 0.060 |
Why?
|
| Hydroxyapatites | 1 | 2023 | 73 | 0.060 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2007 | 260 | 0.060 |
Why?
|
| Prenatal Diagnosis | 5 | 1989 | 1271 | 0.050 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 26325 | 0.050 |
Why?
|
| Heart Rate | 2 | 2011 | 4209 | 0.050 |
Why?
|
| Surgical Equipment | 1 | 2003 | 57 | 0.050 |
Why?
|
| Carcinoma | 1 | 2015 | 2326 | 0.050 |
Why?
|
| Motor Neurons | 2 | 2007 | 869 | 0.050 |
Why?
|
| Gastric Bypass | 1 | 2012 | 820 | 0.050 |
Why?
|
| Cystic Fibrosis | 2 | 1992 | 1292 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2018 | 3683 | 0.050 |
Why?
|
| Fixation, Ocular | 1 | 2005 | 243 | 0.050 |
Why?
|
| Methylmethacrylate | 1 | 2003 | 39 | 0.050 |
Why?
|
| Age Factors | 9 | 2012 | 18401 | 0.050 |
Why?
|
| Sensory Thresholds | 2 | 1997 | 377 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2008 | 752 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 382 | 0.050 |
Why?
|
| Hand | 3 | 2008 | 910 | 0.050 |
Why?
|
| alpha-Fetoproteins | 1 | 2023 | 229 | 0.050 |
Why?
|
| Adenoma | 1 | 2013 | 2155 | 0.050 |
Why?
|
| Radiotherapy Dosage | 1 | 2009 | 2915 | 0.050 |
Why?
|
| Negotiating | 1 | 2024 | 152 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 1995 | 3834 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 2 | 2012 | 2930 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 1989 | 1873 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 1999 | 13411 | 0.050 |
Why?
|
| Health Status | 1 | 1995 | 4091 | 0.050 |
Why?
|
| Infusions, Intravenous | 3 | 2012 | 2227 | 0.050 |
Why?
|
| Diagnosis, Differential | 4 | 2012 | 12986 | 0.050 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 1217 | 0.050 |
Why?
|
| Germany | 2 | 2014 | 882 | 0.050 |
Why?
|
| Dioxanes | 1 | 2021 | 36 | 0.050 |
Why?
|
| Occupational Health | 1 | 2008 | 812 | 0.050 |
Why?
|
| Equipment Safety | 1 | 2022 | 250 | 0.050 |
Why?
|
| Boston | 2 | 2017 | 9360 | 0.050 |
Why?
|
| Headache | 2 | 2024 | 1261 | 0.050 |
Why?
|
| Air | 1 | 2021 | 186 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 1999 | 17608 | 0.050 |
Why?
|
| Disease Progression | 4 | 2017 | 13646 | 0.050 |
Why?
|
| Energy Metabolism | 3 | 1989 | 2906 | 0.050 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2009 | 928 | 0.050 |
Why?
|
| Massachusetts | 4 | 2018 | 8890 | 0.050 |
Why?
|
| Auditory Cortex | 1 | 2005 | 366 | 0.040 |
Why?
|
| Interferometry | 2 | 1991 | 101 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 2011 | 1807 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2014 | 3797 | 0.040 |
Why?
|
| Blood Flow Velocity | 2 | 2017 | 1374 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2009 | 1677 | 0.040 |
Why?
|
| Hearing Disorders | 1 | 2000 | 126 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2013 | 4498 | 0.040 |
Why?
|
| Registries | 3 | 2017 | 8351 | 0.040 |
Why?
|
| Acoustic Stimulation | 1 | 2005 | 1253 | 0.040 |
Why?
|
| Circle of Willis | 2 | 2015 | 77 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 5519 | 0.040 |
Why?
|
| Lung | 3 | 1999 | 10076 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2011 | 9660 | 0.040 |
Why?
|
| Bone Density Conservation Agents | 1 | 2007 | 797 | 0.040 |
Why?
|
| Abdomen | 2 | 2014 | 1138 | 0.040 |
Why?
|
| Optic Chiasm | 1 | 2000 | 91 | 0.040 |
Why?
|
| Program Development | 2 | 2017 | 1298 | 0.040 |
Why?
|
| Amnesia, Transient Global | 1 | 1999 | 19 | 0.040 |
Why?
|
| Drosophila | 2 | 1999 | 1509 | 0.040 |
Why?
|
| Life Tables | 1 | 1999 | 367 | 0.040 |
Why?
|
| Motor Cortex | 1 | 2007 | 1005 | 0.040 |
Why?
|
| Medical Errors | 2 | 2022 | 1260 | 0.040 |
Why?
|
| Creatinine | 2 | 2013 | 1916 | 0.040 |
Why?
|
| Ultrasonography | 6 | 2001 | 6000 | 0.040 |
Why?
|
| Smoking | 2 | 1996 | 9081 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2011 | 3370 | 0.040 |
Why?
|
| Models, Molecular | 3 | 1999 | 5388 | 0.040 |
Why?
|
| Jaw, Edentulous | 1 | 1999 | 94 | 0.040 |
Why?
|
| Respiratory Mechanics | 2 | 1994 | 720 | 0.040 |
Why?
|
| Dominance, Cerebral | 1 | 2000 | 616 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 1233 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5332 | 0.040 |
Why?
|
| Thermosensing | 1 | 1998 | 56 | 0.040 |
Why?
|
| Angiography | 2 | 2014 | 1597 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2016 | 1456 | 0.040 |
Why?
|
| Static Electricity | 1 | 1999 | 258 | 0.040 |
Why?
|
| Research Report | 2 | 2012 | 368 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 6507 | 0.040 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2005 | 807 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 3 | 2021 | 7469 | 0.040 |
Why?
|
| Quarantine | 1 | 2020 | 186 | 0.040 |
Why?
|
| Arteries | 1 | 2003 | 1123 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1999 | 373 | 0.040 |
Why?
|
| Osseointegration | 1 | 1999 | 271 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 1999 | 512 | 0.040 |
Why?
|
| Nystagmus, Physiologic | 1 | 1997 | 29 | 0.040 |
Why?
|
| Abdominal Muscles | 3 | 1994 | 172 | 0.040 |
Why?
|
| Supratentorial Neoplasms | 1 | 1999 | 156 | 0.040 |
Why?
|
| Accreditation | 2 | 2012 | 477 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 1995 | 9612 | 0.040 |
Why?
|
| Gallium | 1 | 1997 | 30 | 0.040 |
Why?
|
| Veterans | 1 | 2011 | 2666 | 0.040 |
Why?
|
| Linoleic Acids | 1 | 1997 | 39 | 0.040 |
Why?
|
| Dimerization | 1 | 1999 | 882 | 0.040 |
Why?
|
| Gels | 1 | 2018 | 421 | 0.040 |
Why?
|
| Hypertension | 1 | 1997 | 8615 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 2000 | 1736 | 0.030 |
Why?
|
| Private Practice | 1 | 2018 | 154 | 0.030 |
Why?
|
| Parietal Lobe | 2 | 2000 | 861 | 0.030 |
Why?
|
| Osteogenesis, Distraction | 1 | 2019 | 233 | 0.030 |
Why?
|
| Dementia | 1 | 2011 | 2741 | 0.030 |
Why?
|
| Oleic Acid | 1 | 1997 | 90 | 0.030 |
Why?
|
| Group Practice | 1 | 2018 | 148 | 0.030 |
Why?
|
| Models, Animal | 1 | 2003 | 2121 | 0.030 |
Why?
|
| Causality | 2 | 2014 | 1253 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 2598 | 0.030 |
Why?
|
| Glucose | 1 | 1989 | 4341 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 5446 | 0.030 |
Why?
|
| Sumatriptan | 1 | 1997 | 66 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2022 | 818 | 0.030 |
Why?
|
| Carotid Artery, External | 1 | 2016 | 37 | 0.030 |
Why?
|
| Receptors, Adrenergic | 2 | 1987 | 155 | 0.030 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 238 | 0.030 |
Why?
|
| Psychophysics | 1 | 1997 | 292 | 0.030 |
Why?
|
| Renal Artery | 1 | 1998 | 355 | 0.030 |
Why?
|
| Perfusion | 1 | 2021 | 1409 | 0.030 |
Why?
|
| Mucus | 2 | 1975 | 346 | 0.030 |
Why?
|
| Anxiety | 2 | 2011 | 4670 | 0.030 |
Why?
|
| Light | 3 | 1991 | 1358 | 0.030 |
Why?
|
| Alveolar Bone Loss | 1 | 1999 | 394 | 0.030 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2000 | 390 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2007 | 1481 | 0.030 |
Why?
|
| Linoleic Acid | 1 | 1997 | 158 | 0.030 |
Why?
|
| Optic Nerve Diseases | 1 | 2000 | 342 | 0.030 |
Why?
|
| Transcription Factors | 1 | 1995 | 12158 | 0.030 |
Why?
|
| Serotonin Receptor Agonists | 1 | 1997 | 151 | 0.030 |
Why?
|
| Stress, Psychological | 2 | 2011 | 4526 | 0.030 |
Why?
|
| Inositol | 1 | 1996 | 216 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1995 | 144 | 0.030 |
Why?
|
| Recurrence | 4 | 2015 | 8504 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 2 | 1997 | 899 | 0.030 |
Why?
|
| Anterior Cerebral Artery | 1 | 2015 | 50 | 0.030 |
Why?
|
| Dental Implantation, Endosseous | 1 | 1999 | 519 | 0.030 |
Why?
|
| Reflex, Stretch | 1 | 1995 | 22 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2017 | 277 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2014 | 1479 | 0.030 |
Why?
|
| Tetrazoles | 1 | 2021 | 923 | 0.030 |
Why?
|
| Masseter Muscle | 1 | 1995 | 38 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 1996 | 203 | 0.030 |
Why?
|
| Australia | 1 | 2019 | 1263 | 0.030 |
Why?
|
| Fatigue | 1 | 2022 | 1556 | 0.030 |
Why?
|
| Benchmarking | 1 | 2021 | 1056 | 0.030 |
Why?
|
| Depression | 3 | 2014 | 8234 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1998 | 793 | 0.030 |
Why?
|
| Trachea | 3 | 1975 | 1095 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2850 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 2745 | 0.030 |
Why?
|
| Choline | 1 | 1996 | 511 | 0.030 |
Why?
|
| Foot | 1 | 1998 | 576 | 0.030 |
Why?
|
| Fibrinolysis | 1 | 2016 | 331 | 0.030 |
Why?
|
| Anesthesia, Intravenous | 1 | 1975 | 130 | 0.030 |
Why?
|
| Solvents | 1 | 1995 | 298 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 363 | 0.030 |
Why?
|
| Infant | 6 | 2014 | 36485 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1995 | 240 | 0.030 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.030 |
Why?
|
| Base Sequence | 2 | 1995 | 12414 | 0.030 |
Why?
|
| Survival Rate | 1 | 2008 | 12823 | 0.030 |
Why?
|
| Liability, Legal | 1 | 2015 | 209 | 0.030 |
Why?
|
| Crystallization | 1 | 1995 | 518 | 0.030 |
Why?
|
| Systole | 1 | 1996 | 935 | 0.030 |
Why?
|
| Crisis Intervention | 1 | 1995 | 111 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 2000 | 947 | 0.030 |
Why?
|
| Diastole | 1 | 1996 | 784 | 0.030 |
Why?
|
| Urinary Catheterization | 1 | 2014 | 195 | 0.030 |
Why?
|
| Cesium Isotopes | 1 | 1973 | 2 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2018 | 698 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 2014 | 3968 | 0.030 |
Why?
|
| Cattle | 1 | 1999 | 3813 | 0.030 |
Why?
|
| Urologic Neoplasms | 1 | 1997 | 312 | 0.030 |
Why?
|
| Pregnancy | 9 | 2012 | 30238 | 0.030 |
Why?
|
| Proprioception | 1 | 1994 | 134 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 781 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2127 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1997 | 1750 | 0.030 |
Why?
|
| Propofol | 1 | 1999 | 608 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2013 | 169 | 0.030 |
Why?
|
| Catheterization | 1 | 1998 | 1430 | 0.030 |
Why?
|
| Anthropometry | 1 | 1997 | 1345 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1998 | 951 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 1677 | 0.030 |
Why?
|
| Thalamus | 1 | 1999 | 1040 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 679 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1998 | 1441 | 0.020 |
Why?
|
| Fetal Diseases | 2 | 1988 | 915 | 0.020 |
Why?
|
| Bronchiectasis | 1 | 1993 | 141 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15645 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1997 | 1652 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2013 | 198 | 0.020 |
Why?
|
| Fetus | 3 | 1988 | 1878 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2000 | 4186 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18330 | 0.020 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2013 | 117 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 14766 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2014 | 381 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2021 | 1982 | 0.020 |
Why?
|
| Biopsy | 1 | 2023 | 6777 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 11097 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1995 | 1882 | 0.020 |
Why?
|
| School Health Services | 1 | 1995 | 388 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13650 | 0.020 |
Why?
|
| Film Dosimetry | 1 | 2011 | 30 | 0.020 |
Why?
|
| Iopamidol | 1 | 2011 | 188 | 0.020 |
Why?
|
| Abnormalities, Multiple | 3 | 1987 | 1424 | 0.020 |
Why?
|
| Motion | 1 | 2014 | 784 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2014 | 1587 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2016 | 956 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 1996 | 903 | 0.020 |
Why?
|
| Arvicolinae | 1 | 2010 | 21 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 793 | 0.020 |
Why?
|
| Visual Acuity | 2 | 1991 | 2714 | 0.020 |
Why?
|
| Schools, Nursing | 1 | 2010 | 4 | 0.020 |
Why?
|
| Physical Fitness | 1 | 1995 | 744 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2647 | 0.020 |
Why?
|
| Societies, Nursing | 1 | 2010 | 22 | 0.020 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2011 | 64 | 0.020 |
Why?
|
| Binding Sites | 2 | 1997 | 6014 | 0.020 |
Why?
|
| Nursing Methodology Research | 1 | 2010 | 64 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2016 | 978 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 1990 | 92 | 0.020 |
Why?
|
| Point Mutation | 1 | 1995 | 1591 | 0.020 |
Why?
|
| Gene Conversion | 1 | 1990 | 69 | 0.020 |
Why?
|
| Chromosomes, Fungal | 1 | 1990 | 110 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1997 | 790 | 0.020 |
Why?
|
| San Francisco | 1 | 2010 | 166 | 0.020 |
Why?
|
| Braces | 1 | 2011 | 139 | 0.020 |
Why?
|
| Cavernous Sinus | 1 | 2011 | 121 | 0.020 |
Why?
|
| Rehabilitation Centers | 1 | 2011 | 249 | 0.020 |
Why?
|
| Research Personnel | 1 | 2015 | 589 | 0.020 |
Why?
|
| Pregnancy, Prolonged | 1 | 1989 | 9 | 0.020 |
Why?
|
| Physician Self-Referral | 1 | 2009 | 16 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2020 | 2926 | 0.020 |
Why?
|
| Fetal Monitoring | 1 | 1989 | 69 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 2012 | 396 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2012 | 592 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2008 | 4968 | 0.020 |
Why?
|
| Pyridines | 1 | 2021 | 2890 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 1716 | 0.020 |
Why?
|
| Credentialing | 1 | 2009 | 114 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2010 | 324 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 12250 | 0.020 |
Why?
|
| Random Allocation | 2 | 2008 | 2394 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1997 | 2900 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1990 | 440 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2021 | 3044 | 0.020 |
Why?
|
| Skin | 1 | 2023 | 4499 | 0.020 |
Why?
|
| Information Management | 1 | 2009 | 100 | 0.020 |
Why?
|
| Urinary Incontinence | 1 | 2013 | 490 | 0.020 |
Why?
|
| Retina | 1 | 2000 | 2659 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1973 | 1987 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 935 | 0.020 |
Why?
|
| Amino Acids | 1 | 1995 | 1712 | 0.020 |
Why?
|
| Dental Arch | 1 | 2008 | 42 | 0.020 |
Why?
|
| Hospices | 1 | 2011 | 245 | 0.020 |
Why?
|
| Fetal Macrosomia | 1 | 1989 | 138 | 0.020 |
Why?
|
| Tooth Injuries | 1 | 2008 | 17 | 0.020 |
Why?
|
| Spina Bifida Occulta | 1 | 1988 | 31 | 0.020 |
Why?
|
| Body Water | 1 | 1989 | 337 | 0.020 |
Why?
|
| Radiography, Panoramic | 1 | 2008 | 111 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2014 | 10455 | 0.020 |
Why?
|
| Internationality | 1 | 2014 | 1006 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 2011 | 635 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1903 | 0.020 |
Why?
|
| Respiration | 1 | 2014 | 1655 | 0.020 |
Why?
|
| Government Programs | 1 | 2010 | 278 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 1993 | 689 | 0.020 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1989 | 437 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2270 | 0.020 |
Why?
|
| Neural Tube Defects | 2 | 1987 | 255 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 1989 | 381 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2016 | 1840 | 0.020 |
Why?
|
| Mandibular Condyle | 1 | 2008 | 118 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3618 | 0.020 |
Why?
|
| Walking | 1 | 2015 | 1201 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2014 | 42606 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2016 | 1142 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 17097 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2011 | 405 | 0.020 |
Why?
|
| Diet, Reducing | 2 | 1985 | 487 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2014 | 3642 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2011 | 409 | 0.020 |
Why?
|
| Professional Competence | 1 | 2010 | 430 | 0.020 |
Why?
|
| Isometric Contraction | 2 | 1999 | 149 | 0.020 |
Why?
|
| American Heart Association | 1 | 2012 | 1049 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 655 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 4052 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3618 | 0.020 |
Why?
|
| Body Weight | 4 | 1996 | 4627 | 0.020 |
Why?
|
| Lipolysis | 1 | 1987 | 211 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2658 | 0.020 |
Why?
|
| Family Practice | 1 | 1969 | 509 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2013 | 1319 | 0.020 |
Why?
|
| Skull | 2 | 1988 | 819 | 0.020 |
Why?
|
| Curriculum | 2 | 2010 | 3786 | 0.020 |
Why?
|
| Esterification | 1 | 1985 | 39 | 0.020 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2010 | 456 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 5753 | 0.020 |
Why?
|
| Cadaver | 1 | 2010 | 1362 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3611 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1991 | 1824 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2007 | 442 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3608 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 771 | 0.020 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2008 | 253 | 0.020 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1999 | 309 | 0.020 |
Why?
|
| Athletic Injuries | 1 | 2015 | 1245 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 1997 | 11872 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2008 | 1139 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 1999 | 22254 | 0.010 |
Why?
|
| Motor Skills | 1 | 2008 | 521 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2011 | 2086 | 0.010 |
Why?
|
| Cell Division | 1 | 1972 | 4473 | 0.010 |
Why?
|
| Glycerol | 1 | 1985 | 274 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1993 | 1240 | 0.010 |
Why?
|
| Life Style | 1 | 1996 | 3931 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2011 | 1467 | 0.010 |
Why?
|
| Electromyography | 3 | 1995 | 1398 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2011 | 1003 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1991 | 1480 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 1997 | 1712 | 0.010 |
Why?
|
| Brain Concussion | 1 | 2015 | 1431 | 0.010 |
Why?
|
| Metabolomics | 1 | 2013 | 1675 | 0.010 |
Why?
|
| Hydrocephalus | 2 | 1988 | 766 | 0.010 |
Why?
|
| Phenobarbital | 1 | 2004 | 192 | 0.010 |
Why?
|
| Mandible | 1 | 2008 | 748 | 0.010 |
Why?
|
| Suicide | 1 | 1995 | 1606 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1996 | 11513 | 0.010 |
Why?
|
| Vertebral Artery | 1 | 2004 | 185 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 1995 | 2085 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 1969 | 1000 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10748 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2011 | 10092 | 0.010 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2008 | 551 | 0.010 |
Why?
|
| Body Height | 1 | 1989 | 1565 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1997 | 11217 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5203 | 0.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1993 | 1481 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 1175 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 2702 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1990 | 2568 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 2030 | 0.010 |
Why?
|
| Tidal Volume | 2 | 1994 | 519 | 0.010 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2000 | 210 | 0.010 |
Why?
|
| Electroencephalography | 3 | 2000 | 6282 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11063 | 0.010 |
Why?
|
| Seizures | 1 | 2012 | 2996 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1987 | 1345 | 0.010 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 1999 | 24 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1990 | 2678 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1979 | 224 | 0.010 |
Why?
|
| Feedback | 2 | 1994 | 797 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 2000 | 236 | 0.010 |
Why?
|
| Mice | 4 | 2014 | 81912 | 0.010 |
Why?
|
| Temperance | 1 | 1999 | 88 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2014 | 12793 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 1999 | 164 | 0.010 |
Why?
|
| Hospitalization | 3 | 2018 | 10815 | 0.010 |
Why?
|
| Form Perception | 1 | 2000 | 175 | 0.010 |
Why?
|
| Tympanic Membrane | 1 | 2000 | 232 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2000 | 504 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9513 | 0.010 |
Why?
|
| Exercise | 2 | 1999 | 5954 | 0.010 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1997 | 17 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2001 | 915 | 0.010 |
Why?
|
| Verbal Learning | 1 | 2000 | 459 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1990 | 2255 | 0.010 |
Why?
|
| Cyclic AMP Receptor Protein | 1 | 1997 | 23 | 0.010 |
Why?
|
| Diffusion | 1 | 1999 | 810 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2011 | 5345 | 0.010 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 1979 | 348 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1990 | 4405 | 0.010 |
Why?
|
| Lipids | 2 | 1986 | 3322 | 0.010 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2007 | 1498 | 0.010 |
Why?
|
| Cerebellum | 1 | 2004 | 1521 | 0.010 |
Why?
|
| Psychiatry | 1 | 1969 | 1715 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2008 | 3078 | 0.010 |
Why?
|
| Fiber Optic Technology | 2 | 1975 | 290 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11657 | 0.010 |
Why?
|
| Communication | 1 | 2011 | 3904 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 1065 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1990 | 3114 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 9410 | 0.010 |
Why?
|
| Reading | 1 | 2000 | 541 | 0.010 |
Why?
|
| Motion Perception | 1 | 2000 | 378 | 0.010 |
Why?
|
| Streptokinase | 1 | 1996 | 186 | 0.010 |
Why?
|
| Vinblastine | 1 | 1997 | 482 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1999 | 910 | 0.010 |
Why?
|
| Thiopental | 1 | 1975 | 55 | 0.010 |
Why?
|
| Visual Pathways | 1 | 2000 | 554 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2000 | 835 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1997 | 685 | 0.010 |
Why?
|
| Tracheitis | 1 | 1975 | 29 | 0.010 |
Why?
|
| Halothane | 1 | 1975 | 200 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 946 | 0.010 |
Why?
|
| Bronchoscopy | 3 | 1975 | 913 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1999 | 901 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 1987 | 2513 | 0.010 |
Why?
|
| Pulmonary Stretch Receptors | 1 | 1994 | 12 | 0.010 |
Why?
|
| Nitrous Oxide | 1 | 1975 | 166 | 0.010 |
Why?
|
| Homeostasis | 1 | 1985 | 3345 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2004 | 1921 | 0.010 |
Why?
|
| Chicago | 1 | 1995 | 255 | 0.010 |
Why?
|
| Software | 1 | 2008 | 4472 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 1979 | 501 | 0.010 |
Why?
|
| Genital Diseases, Female | 1 | 1975 | 192 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1999 | 3052 | 0.010 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 1993 | 30 | 0.010 |
Why?
|
| Potassium Isotopes | 1 | 1973 | 9 | 0.010 |
Why?
|
| Sepsis | 1 | 1987 | 2605 | 0.010 |
Why?
|
| Mass Screening | 1 | 1989 | 5456 | 0.010 |
Why?
|
| Thallium | 1 | 1973 | 97 | 0.010 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 1993 | 80 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3344 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 1999 | 6215 | 0.010 |
Why?
|
| Pleura | 1 | 1994 | 245 | 0.010 |
Why?
|
| Respiratory Function Tests | 2 | 1994 | 1695 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 1993 | 172 | 0.010 |
Why?
|
| Sheep | 1 | 1975 | 1449 | 0.010 |
Why?
|
| Oxygen | 2 | 1993 | 4252 | 0.010 |
Why?
|
| Functional Residual Capacity | 1 | 1992 | 70 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1993 | 211 | 0.010 |
Why?
|
| Norway | 2 | 1972 | 500 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 2 | 1972 | 317 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1993 | 389 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1994 | 458 | 0.010 |
Why?
|
| Respiratory Muscles | 1 | 1992 | 144 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2000 | 1446 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1993 | 683 | 0.010 |
Why?
|
| Cisplatin | 1 | 1997 | 1656 | 0.010 |
Why?
|
| Dealkylation | 1 | 1990 | 2 | 0.010 |
Why?
|
| Spores, Fungal | 1 | 1990 | 89 | 0.010 |
Why?
|
| Methotrexate | 1 | 1997 | 1718 | 0.010 |
Why?
|
| Doxorubicin | 1 | 1997 | 2229 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 1990 | 190 | 0.010 |
Why?
|
| Tomatine | 1 | 1989 | 1 | 0.010 |
Why?
|
| Memory | 1 | 2000 | 2192 | 0.010 |
Why?
|
| Phloretin | 1 | 1989 | 16 | 0.010 |
Why?
|
| Methylglucosides | 1 | 1989 | 35 | 0.010 |
Why?
|
| 3-O-Methylglucose | 1 | 1989 | 37 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1989 | 74 | 0.010 |
Why?
|
| Infant, Postmature | 1 | 1989 | 11 | 0.010 |
Why?
|
| Stomach | 1 | 1994 | 701 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1994 | 1137 | 0.010 |
Why?
|
| Cortisone | 1 | 1990 | 90 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1972 | 392 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1999 | 6331 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1989 | 323 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1990 | 191 | 0.010 |
Why?
|
| Tritium | 1 | 1989 | 707 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1990 | 158 | 0.010 |
Why?
|
| Thrombophlebitis | 1 | 1990 | 289 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1990 | 624 | 0.000 |
Why?
|
| Models, Genetic | 1 | 1999 | 3445 | 0.000 |
Why?
|
| Deoxyglucose | 1 | 1989 | 322 | 0.000 |
Why?
|
| Triglycerides | 2 | 1987 | 2444 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1989 | 453 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1990 | 915 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1989 | 654 | 0.000 |
Why?
|
| Heparin | 1 | 1996 | 1636 | 0.000 |
Why?
|
| Meiosis | 1 | 1990 | 326 | 0.000 |
Why?
|
| Lymphatic Diseases | 1 | 1990 | 318 | 0.000 |
Why?
|
| Repressor Proteins | 1 | 1999 | 2979 | 0.000 |
Why?
|
| Dogs | 1 | 1973 | 3834 | 0.000 |
Why?
|
| Scattering, Radiation | 1 | 1989 | 486 | 0.000 |
Why?
|
| Theophylline | 1 | 1987 | 133 | 0.000 |
Why?
|
| Posture | 1 | 1992 | 956 | 0.000 |
Why?
|
| Permeability | 1 | 1989 | 721 | 0.000 |
Why?
|
| Isoproterenol | 1 | 1987 | 398 | 0.000 |
Why?
|
| Equipment Failure | 1 | 1990 | 585 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1999 | 4209 | 0.000 |
Why?
|
| Clonidine | 1 | 1987 | 170 | 0.000 |
Why?
|
| Extraembryonic Membranes | 1 | 1986 | 37 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1990 | 812 | 0.000 |
Why?
|
| Carrier Proteins | 1 | 1999 | 4925 | 0.000 |
Why?
|
| Cholesterol, VLDL | 1 | 1986 | 70 | 0.000 |
Why?
|
| Mutation | 1 | 1990 | 30211 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1990 | 1524 | 0.000 |
Why?
|
| Plasmids | 1 | 1990 | 2268 | 0.000 |
Why?
|
| Limb Deformities, Congenital | 1 | 1986 | 136 | 0.000 |
Why?
|
| Biological Transport | 1 | 1989 | 2084 | 0.000 |
Why?
|
| Protein Binding | 1 | 1997 | 9327 | 0.000 |
Why?
|
| Lipoproteins, VLDL | 1 | 1986 | 198 | 0.000 |
Why?
|
| Affect | 1 | 1973 | 1494 | 0.000 |
Why?
|
| Hernia, Umbilical | 1 | 1986 | 102 | 0.000 |
Why?
|
| Social Support | 1 | 1995 | 2192 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1996 | 3561 | 0.000 |
Why?
|
| Thorax | 1 | 1986 | 556 | 0.000 |
Why?
|
| Kinetics | 1 | 1989 | 6287 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1990 | 2875 | 0.000 |
Why?
|
| Face | 1 | 1987 | 1029 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 1993 | 26396 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1990 | 1396 | 0.000 |
Why?
|
| Gestational Age | 1 | 1989 | 3618 | 0.000 |
Why?
|
| Feeding Behavior | 1 | 1972 | 3207 | 0.000 |
Why?
|
| Cholesterol, HDL | 1 | 1986 | 1816 | 0.000 |
Why?
|
| Scoliosis | 1 | 1986 | 793 | 0.000 |
Why?
|
| Fatty Acids, Essential | 1 | 1959 | 97 | 0.000 |
Why?
|
| Fats | 1 | 1959 | 99 | 0.000 |
Why?
|
| Cholesterol | 1 | 1986 | 2905 | 0.000 |
Why?
|
| Psychotic Disorders | 1 | 1972 | 3275 | 0.000 |
Why?
|
| Cholesterol, LDL | 1 | 1986 | 2392 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1999 | 23621 | 0.000 |
Why?
|
| Rats | 1 | 1972 | 23713 | 0.000 |
Why?
|
| Genotype | 1 | 1990 | 13035 | 0.000 |
Why?
|
| Cell Line | 1 | 1989 | 15567 | 0.000 |
Why?
|
| Depression, Chemical | 1 | 1975 | 186 | 0.000 |
Why?
|
| Pentobarbital | 1 | 1975 | 153 | 0.000 |
Why?
|
| Macrophages | 1 | 1989 | 5785 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 1988 | 2971 | 0.000 |
Why?
|
| Starvation | 1 | 1973 | 141 | 0.000 |
Why?
|
| Social Work, Psychiatric | 1 | 1972 | 21 | 0.000 |
Why?
|
| Hostility | 1 | 1973 | 185 | 0.000 |
Why?
|
| Paranoid Disorders | 1 | 1972 | 61 | 0.000 |
Why?
|
| Mucous Membrane | 1 | 1975 | 659 | 0.000 |
Why?
|
| Psychophysiologic Disorders | 1 | 1973 | 222 | 0.000 |
Why?
|
| Kidney | 1 | 1986 | 7063 | 0.000 |
Why?
|
| Cilia | 1 | 1975 | 498 | 0.000 |
Why?
|
| Personality Inventory | 1 | 1973 | 1018 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1969 | 6873 | 0.000 |
Why?
|
| Aggression | 1 | 1973 | 748 | 0.000 |
Why?
|
| Self Concept | 1 | 1973 | 1041 | 0.000 |
Why?
|
| Home Care Services | 1 | 1972 | 659 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1972 | 1653 | 0.000 |
Why?
|